Gilead Shot Prevents All HIV Cases in Trial of African Women
Gilead Sciences Inc.’s experimental twice-yearly shot prevented 100% of HIV cases in women and adolescent girls in Africa, the first successful big trial of what’s hoped to become a powerful new drug regimen for fending off the virus.
Lenacapavir will provide an easier-to-use option compared to other HIV prevention drugs that are either daily pills or must be injected every two months. https://www.msn.com/en-us/health/other/gilead-shot-prevents-all-hiv-cases-in-trial-of-african-women/ar-BB1oAfz8
Mark Pesce /
npub1ul…6g320
2024-06-20 21:01:54
Author Public Key
npub1ulje69qvmz2jnj7klz2ph73gl0v3glvyurjh2a2uyztcg7q5vnxq26g320Published at
2024-06-20 21:01:54Event JSON
{
"id": "ff5a06f56dfb0151ab4ebc383e0307c944c20e7f0a7e6f85b8dc07ae34398b33",
"pubkey": "e7e59d140cd89529cbd6f8941bfa28fbd9147d84e0e575755c209784781464cc",
"created_at": 1718917314,
"kind": 1,
"tags": [
[
"proxy",
"https://arvr.social/@mpesce/112650965150029551",
"web"
],
[
"proxy",
"https://arvr.social/users/mpesce/statuses/112650965150029551",
"activitypub"
],
[
"L",
"pink.momostr"
],
[
"l",
"pink.momostr.activitypub:https://arvr.social/users/mpesce/statuses/112650965150029551",
"pink.momostr"
]
],
"content": "Gilead Shot Prevents All HIV Cases in Trial of African Women\n\nGilead Sciences Inc.’s experimental twice-yearly shot prevented 100% of HIV cases in women and adolescent girls in Africa, the first successful big trial of what’s hoped to become a powerful new drug regimen for fending off the virus.\n\nLenacapavir will provide an easier-to-use option compared to other HIV prevention drugs that are either daily pills or must be injected every two months. https://www.msn.com/en-us/health/other/gilead-shot-prevents-all-hiv-cases-in-trial-of-african-women/ar-BB1oAfz8",
"sig": "455267a8557d1179290076ce0bbf2a8c803d8469c399c06a189c167c458bfea6b7a578a0d137441b9d28c039cf1cc722d5afca17a222b843d480fd4243121fa9"
}